Cited by 46Adipokines, Inflammation, and Metabolic DiseasesImmune Response and InflammationInflammasome and immune disorders

Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?

Open access
Tate, Amit R., Rao, Gundu H. R.·2024·Biomolecules

Abstract

Inflammation is the body’s non-specific response to injury or infection. It is a natural defense mechanism that helps to maintain homeostasis and promotes tissue repair. However, excessive inflammation can lead to cellular, tissue, or organ dysfunction, as well as contribute to the development of acute vascular events and diseases like Crohn’s disease, psoriasis, obesity, diabetes, and cancer. The initial response to injury involves the activation of platelets and coagulation mechanisms to stop bleeding. This is followed by the recruitment of immune cells and the release of cytokines to promote tissue repair. Over time, the injured tissue undergoes remodeling and returns to its pre-injury state. Inflammation is characterized by the activation of inflammatory signaling pathways involving cytokines, chemokines, and growth factors. Mast cells play a role in initiating inflammatory responses. Pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and nucleotide-binding domain (NOD)-like receptors (NLRs) are involved in the activation of these inflammatory pathways. Inflammasomes, which are cytoplasmic complexes, also contribute to inflammation by activating cytokines. Inflammation can also be triggered by factors like dietary components and the composition of the gut microbiota. Dysregulation of the gut microbiome can lead to excessive inflammation and contribute to diseases like atherosclerosis and irritable bowel syndrome (IBS). The immune system and gut-associated lymphoid tissue (GALT) play crucial roles in the inflammatory response and the development of conditions like colorectal cancer. Anti-inflammatory therapy can play a significant role in reducing or inducing the remission of inflammatory diseases such as Crohn’s disease and ulcerative colitis. The fetal origin of adult diseases theory suggests that conditions during fetal development, such as low birth weight and maternal obesity, can influence the risk of cardiometabolic diseases later in life. All of the known risk factors associated with cardiometabolic diseases such as hypertension, excess weight, obesity, type-2 diabetes, and vascular diseases are accompanied by chronic low-grade inflammation. Inflammation seems to have a role in precipitating even acute vascular events such as heart attacks and stroke. Common markers of inflammation associated with cardiometabolic disease include interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF-α), C-reactive protein (CRP), and soluble TNF receptors such as sTNFR1 and sTNFR2. These markers serve as indicators of systemic inflammation. However, these markers are not disease-specific but provide an insight into the overall chronic inflammatory status. In fact, inflammation has been identified as a potential target for future treatments to reduce or reverse the risk of atherosclerosis-related complications. The regulation of inflammation is complex, and further research is needed to better understand its mechanisms and develop strategies for managing inflammatory disorders. In summary, inflammation is a natural response to injury or infection, but excessive or prolonged inflammation can lead to the progression of various diseases. Understanding the underlying mechanisms of inflammation is important for developing treatments and preventive measures for inflammatory disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom14080948

Cites

119 of 121 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Psoriasis is a systemic inflammatory condition associated with comorbidities such as cardiometabolic disease.

    “Psoriasis is increasingly recognized as a systemic inflammatory condition associated with comorbidities such as cardiometabolic disease, which has influenced treatment goals toward achieving sustained disease control and potentially modifying long-term inflammatory burden [34,35].”

    From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [35]

    The Abstract and Introduction identify psoriasis as a condition involving inflammation. They do not say that psoriasis is systemic or that people with psoriasis have cardiometabolic comorbidities; the paper discusses cardiometabolic inflammation more generally. (LLM, conf=0.79)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [40]Schulz G.S. Chin G.A. Moldawer L. Diegelmann R. Principles of wound healing Mechanisms of Vascular Disease Fitridge R. Thompson M. University of Adelaide Press Adelaide, Australia 2011 Available online: https://www.ncbi.nlm.nih.gov/books/NBK534261/ (accessed on 30 July 2024) 30485016
  2. [122]Regmi M. Siccardi M.A. Coronary Artery Disease Prevention StatPearls StatPearls Treasure Island, FL, USA 2023 Available online: https://www.ncbi.nlm.nih.gov/books/NBK547760/ (accessed on 30 July 2024) 31613540

Cited by

Sorted by citations

Authors
Tate, A. R., & Rao, G. H. R.
Affiliations
  • South Asian Society on Atherosclerosis and Thrombosis (SASAT), Minneapolis, MN 55455, USA
  • University of Minnesota (US)
Corresponding author
Rao, Gundu H. R.
Venue
Biomolecules
Publisher
MDPI AG
Published
2024-08-06
Volume
14
Issue
8
Pages
948
ISSN
2218-273X (ISSN-L)
OpenAlex
W4401358603
Cited by
42
References
119
Citations by year
2026: 20 · 2025: 20 · 2024: 2
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Heart, Blood, and Lung Institute (NHLBI) of the National Institutes of Health (NIH), USA
  • National Science Foundation (NSF), USA (1980), the United Nations Development Program (UNDP)
  • International Society on Thrombosis and Hemostasis (ISTH), USA
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
cardiometabolic disease, low-grade inflammation, inflammatory markers, C-reactive protein, interleukin-6, TNF-α, soluble TNF receptors, gut microbiota, gut-associated lymphoid tissue, inflammasome, Toll-like receptors, NOD-like receptors, mast cells, Crohn's disease, ulcerative colitis, atherosclerosis, irritable bowel syndrome, anti-inflammatory therapy
MeSH terms
Gastrointestinal Microbiome, Cardiometabolic Risk Factors, Animals, Cardiovascular Diseases, Humans, Inflammation, Cytokines, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review